Find us at Booth #415 to discuss how we can help you chart a new Medical Affairs path toward a more patient-centric drug and device development pipeline.
The biopharma and MedTech industries are experiencing unprecedented change, moving toward a more patient-centric approach to drug and device development.
Medical affairs teams play a crucial role in bridging the gap between research and development (R&D) teams and commercial teams, incorporating patient insights throughout the drug development continuum.
Driven by real-world evidence (RWE), omnichannel engagement and generative AI technologies, Syneos Health Medical Affairs is innovating to drive strategic medical transformation and help companies chart a new path toward a more patient-centric drug and development pipeline.
Meet with Us
Find us at booth #415 or schedule a meeting to learn how you can super-charge Medical Affairs to amplify your science to communicate value and improve patient care.